ALB and Hepatic fibrosis: Patients in the Pre‐SVR group were significantly younger (P = .018), had significantly more preserved liver functions, i.e. albumin level (P < .001), platelet count (P < .001); and significantly lower liver fibrosis (P < .001) than those in the Non‐SVR group.